The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
Institutional review committee approval was obtained. Patients referred for arterial duplex scanning were examined for the presence of foot lesions and the presence of pedal pulses (dorsalis pedis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback